topicBerberine Pcos Meta-Analysis
claimAccording to the Rotterdam criteria established in 2003 and their subsequent refinement in the latest International Evidence-Based Guidelines for the Assessment and Management of PCOS, the syndrome is characterized by the presence of at least two of the following features: clinical and/or biochemical hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology [].
evidence level3
citationLinares Rosa (2026)
sourceNatural Bioactive Compounds in Polycystic Ovary Syndrome: Properties, Molecular Mechanisms, and Therapeutic Potential
topicBerberine Pcos Meta-Analysis
claimPCOS is also associated with insulin resistance (IR), obesity, dyslipidemia, and an increased risk of developing type 2 diabetes mellitus, cardiovascular disease (CVD), and mood disorders [,].
evidence level3
citationLinares Rosa (2026)
sourceNatural Bioactive Compounds in Polycystic Ovary Syndrome: Properties, Molecular Mechanisms, and Therapeutic Potential
topicBerberine Pcos Meta-Analysis
claimImportantly, current International Evidence-Based Guidelines emphasize lifestyle interventions—including dietary modifications, physical activity, and behavioral strategies—as the first-line approach for managing both the metabolic and reproductive manifestations of PCOS [,].
evidence level3
citationLinares Rosa (2026)
sourceNatural Bioactive Compounds in Polycystic Ovary Syndrome: Properties, Molecular Mechanisms, and Therapeutic Potential
topicBerberine Pcos Meta-Analysis
claim1 1 2 Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrinopathies affecting women of reproductive age, with an estimated global prevalence ranging from 8% to 13%, although this varies depending on the diagnostic criteria applied and the characteristics of the studied population.
evidence level3
citationLinares Rosa (2026)
sourceNatural Bioactive Compounds in Polycystic Ovary Syndrome: Properties, Molecular Mechanisms, and Therapeutic Potential
topicBerberine Pcos Meta-Analysis
claimImportantly, PCOS is strongly associated with significant metabolic disturbances, such as insulin resistance (IR) and dyslipidemia, which elevate the long-term risk for type 2 diabetes and cardiovascular morbidity [,].
evidence level3
citationLiu Siqi (2026)
sourceNatural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives
topicBerberine Pcos Meta-Analysis
claimMetformin improves metabolic parameters as an insulin sensitizer [], but its use is limited by gastrointestinal side effects, variable efficacy, and insufficient evidence as a monotherapy on the core reproductive features like ovulation and hirsutism [].
evidence level3
citationLiu Siqi (2026)
sourceNatural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives
topicBerberine Pcos Meta-Analysis
claimPreclinical and clinical studies indicate that natural products such as quercetin, resveratrol, berberine, curcumin, and rutin can exert pleiotropic effects, including enhanced insulin sensitivity, reduced oxidative stress, mitigated chronic inflammation, and modulated hormonal activity.
evidence level3
citationLiu Siqi (2026)
sourceNatural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives
topicBerberine Pcos Meta-Analysis
claim1 2 3 4 5 6 7 Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine–metabolic disorders, affecting approximately 5–18% of reproductive-aged women worldwide [].
evidence level3
citationLiu Siqi (2026)
sourceNatural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives
topicBerberine Pcos Meta-Analysis
claimPatients commonly exhibit increased levels of 17-Hydroxyprogesterone, dehydroepiandrosterone sulfate (DHEAS), androstenedione, anti-Müllerian hormone (AMH), and an elevated luteinizing hormone (LH) to follicle-stimulating hormone (FSH) ratio, which disrupts normal follicular development ().
evidence level4
citationNandagopal Prasanth Babu (2026)
sourceIntegrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications
topicBerberine Pcos Meta-Analysis
claimAs a result, follicular maturation is arrested at the small antral stage (4–8 mm), preventing the formation of a dominant follicle and contributing to chronic anovulation and infertility.
evidence level4
citationNandagopal Prasanth Babu (2026)
sourceIntegrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications
topicBerberine Pcos Meta-Analysis
claim9 10 7 11 12 13 14 Epidemiological studies indicate that PCOS is associated with a range of adverse metabolic, reproductive, and psychological outcomes ().
evidence level4
citationNandagopal Prasanth Babu (2026)
sourceIntegrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications
topicBerberine Pcos Meta-Analysis
claim1 2 3 Figure 1 4 5 6 7 8 in utero Among women of reproductive age, polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine disorders With an estimated global burden of 69.5 million affected individuals and increasing years lived with disability (YLDs), PCOS represents a major public health challenge.
evidence level4
citationNandagopal Prasanth Babu (2026)
sourceIntegrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications